Current Alzheimer Research logo Bentham Science Publishers logo

Current Alzheimer Research publishes peer-reviewed frontier review and research articles on all areas of Alzheimer's disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer's disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer's disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer's disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer's disease. Current Alzheimer Research provides a comprehensive 'bird's-eye view' of the current state of Alzheimer's research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

Publisher: Bentham Science Publishers

Volume 4, Number 4, September 2007
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Articles

Cholinotrophic Molecular Substrates of Mild Cognitive Impairment in the Elderly
pp. 340-350(11)
Authors: Mufson, Elliott J.; Counts, Scott E.; Fahnestock, Margaret; Ginsberg, Stephen D.

NGF-Cholinergic Dependency in Brain Aging, MCI and Alzheimer's Disease
pp. 351-358(8)
Authors: Cuello, A. C.; Bruno, A.; Bell, K.F. S.

Computerized Methods in the Assessment and Prediction of Dementia
pp. 364-369(6)
Authors: Korczyn, Amos D.; Aharonson, Vered

Practical Issues in Stem Cell Therapy for Alzheimer's Disease
pp. 370-377(8)
Authors: Sugaya, K.; Kwak, Y. D.; Ohmitsu, O.; Marutle, A.; Greig, N. H.; Choumrina, E.

TNF-α Inhibition as a Treatment Strategy for Neurodegenerative Disorders: New Drug Candidates and Targets
pp. 378-385(8)
Authors: Tweedie, David; Sambamurti, Kumar; Greig, Nigel H.

East Meets West in the Search for Alzheimer's Therapeutics - Novel Dimeric Inhibitors from Tacrine and Huperzine A
pp. 386-396(11)
Authors: Li, W. M.; Kan, K. K.W.; Carlier, P. R.; Pang, Y. P.; Han, Y. F.

N-Phenylamine Derivatives as Aggregation Inhibitors in Cell Models of Tauopathy
pp. 397-402(6)
Authors: Pickhardt, M.; Biernat, J.; Khlistunova, I.; Wang, Y.-P.; Gazova, Z.; Mandelkow, E.-M.; Mandelkow, E.

Neurorescue Activity, APP Regulation and Amyloid-β Peptide Reduction by Novel Multi-Functional Brain Permeable Iron- Chelating- Antioxidants,M-30 and Green Tea Polyphenol, EGCG
pp. 403-411(9)
Authors: Avramovich-Tirosh, Yael; Reznichenko, Lydia; Amit, Tamar; Zheng, Hailin; Fridkin, Mati; Weinreb, Orly; Mandel, Silvia; Youdim, Moussa B.H.

Alpha-Secretase As a Therapeutic Target
pp. 412-417(6)
Author: Fahrenholz, Falk

Memapsin 2 (Beta-Secretase) Inhibitor Drug, between Fantasy and Reality
pp. 418-422(5)
Authors: Ghosh, Arun K.; Bilcer, Geoffrey; Hong, Lin; Koelsch, Gerald; Tang, Jordan

The γ /η-Secretase-Derived APP Intracellular Domain Fragments Regulate p53
pp. 423-426(4)
Authors: Checler, Frederic; Sunyach, Claire; Pardossi-Piquard, Raphaelle; Sevalle, Jean; Vincent, Bruno; Kawarai, Toshitaka; Girardot, Nadege; George-Hyslop, Peter St; da Costa, Cristine A.

Novel Aβ Immunogens: Is Shorter Better?
pp. 427-436(10)
Authors: Lemere, Cynthia A.; Maier, Marcel; Peng, Ying; Jiang, Liying; Seabrook, Timothy J.

Is alpha-Synuclein Pathology a Target for Treatment of Neurodegenerative Disorders?
pp. 446-457(12)
Authors: Windisch, M.; Wolf, H. J.; Hutter-Paier, B.; Hofmeister, A.; Wronski, R.

Lessons from Darwin: 21st Century Designs for Clinical Trials
pp. 458-467(10)
Author: Becker, Robert E.

Drug Trials in Dementia: Challenging Ethical Dilemmas
pp. 468-472(5)
Author: Korczyn, Amos D.

Alzhemed: A Potential Treatment for Alzheimer's Disease
pp. 473-478(6)
Authors: Aisen, Paul S.; Gauthier, Serge; Vellas, Bruno; Briand, Richard; Saumier, Daniel; Laurin, Julie; Garceau, Denis

Pharmacogenetic Aspects of Therapy with Cholinesterase Inhibitors: The Role of CYP2D6 in Alzheimer's Disease Pharmacogenetics
pp. 479-500(22)
Authors: Cacabelos, Ramon; Llovo, Ruth; Fraile, Carmen; Fernandez-Novoa, Lucia

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A